CD8A and neoplasm: Immune profiling of resected tumor tissues revealed greater tumor infiltration of CD3+, CD3+ CD8+ T lymphocytes and of other immune cell populations, compared to pretreatment tissues, in those patients receiving nivolumab + ipilimumab, thus suggesting that treatment with dual ICIs enhances the immunologic memory.